Contrast induced nephropathy in patients with pre-existing renal impairment undergoing invasive coronary procedures — a long-term follow-up

Akash Dhawan, Devang Parikh, Ibrahim Shugman, John French, Hisham Hallani, Clyne Fernandes and Craig P Juergens
Med J Aust 2011; 195 (5): . || doi: 10.5694/mja11.10368
Published online: 5 September 2011

To the Editor: Contrast induced nephropathy (CIN) is one of the most important and frequent complications of invasive coronary procedures.1 We have previously reported a multicentre randomised trial comparing use of iso-osmolar and low osmolar contrast agents (iopromide and iodixanol, respectively) in patients with pre-existing renal impairment.2 The overall proportion of patients developing CIN by Day 7 was around 25%, and there was no statistical difference between the different contrast media.

  • Akash Dhawan1
  • Devang Parikh1
  • Ibrahim Shugman2
  • John French1
  • Hisham Hallani3
  • Clyne Fernandes3
  • Craig P Juergens1

  • 1 Liverpool Hospital, Sydney, NSW.
  • 2 South Western Sydney Clinical School, University of New South Wales, Sydney, NSW
  • 3 Nepean Hospital, Sydney, NSW.


Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.